{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:02:29Z","timestamp":1790301749663,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI146771-01"],"award-info":[{"award-number":["AI146771-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI139369-01"],"award-info":[{"award-number":["AI139369-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015158","name":"Fondren Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015190","name":"Houston Methodist Hospital and Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ajpath.2020.04.014","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T11:44:59Z","timestamp":1589197499000},"page":"1625-1631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["A Single Amino Acid Replacement in Penicillin-Binding Protein 2X in Streptococcus pyogenes Significantly Increases Fitness on Subtherapeutic Benzylpenicillin Treatment in a Mouse Model of Necrotizing\u00a0Myositis"],"prefix":"10.1016","volume":"190","author":[{"given":"Randall J.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luchang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Musser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2020.04.014_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajpath.2020.04.014_bib2","first-page":"1","article-title":"Group a streptococcal diseases and their global burden","volume":"368","author":"Ralph","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ajpath.2020.04.014_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM200101183440308","article-title":"Acute pharyngitis","volume":"344","author":"Bisno","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2020.04.014_bib4","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing soft-tissue infections","volume":"377","author":"Stevens","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2020.04.014_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of group A Streptococcus","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ajpath.2020.04.014_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2020.04.014_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJMcp1009126","article-title":"Clinical practice: streptococcal pharyngitis","volume":"364","author":"Wessels","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2020.04.014_bib8","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1016\/j.vaccine.2018.02.068","article-title":"WHO\/IVI global stakeholder consultation on group A Streptococcus vaccine development: report from a meeting held on 12-13 December 2016","volume":"36","author":"Osowicki","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ajpath.2020.04.014_bib9","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.vaccine.2017.02.060","article-title":"Clinical development strategy for a candidate group A streptococcal vaccine","volume":"35","author":"Schodel","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ajpath.2020.04.014_bib10","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","article-title":"Status of research and development of vaccines for Streptococcus pyogenes","volume":"34","author":"Steer","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.ajpath.2020.04.014_bib11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciy1143","article-title":"The path to group A Streptococcus vaccines: World Health Organization research and development technology roadmap and preferred product characteristics","volume":"69","author":"Vekemans","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2020.04.014_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jamapediatrics.2014.1582","article-title":"Overprescribing and inappropriate antibiotic selection for children with pharyngitis in the United States, 1997-2010","volume":"168","author":"Dooling","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajpath.2020.04.014_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/cid\/ciz225","article-title":"Changes in US outpatient antibiotic prescriptions from 2011-2016","volume":"70","author":"King","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2020.04.014_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1542\/pir.19.9.291","article-title":"Group A beta-hemolytic streptococcal infections","volume":"19","author":"Pichichero","year":"1998","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.ajpath.2020.04.014_bib15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1086\/516375","article-title":"Why have group A streptococci remained susceptible to penicillin? report on a symposium","volume":"26","author":"Horn","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2020.04.014_bib16","doi-asserted-by":"crossref","first-page":"e01993-19","DOI":"10.1128\/JCM.01993-19","article-title":"Reduced in\u00a0vitro susceptibility of Streptococcus pyogenes to beta-lactam antibiotics associated with mutations in the pbp2x gene is geographically widespread","volume":"58","author":"Musser","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajpath.2020.04.014_bib17","first-page":"1265","article-title":"Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to beta-lactam antibiotics","volume":"70","author":"Vannice","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajpath.2020.04.014_bib18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10096-018-3278-7","article-title":"High isolation rate and multidrug resistance tendency of penicillin-susceptible group B Streptococcus with reduced ceftibuten susceptibility in Japan","volume":"37","author":"Banno","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ajpath.2020.04.014_bib19","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1128\/AAC.00461-08","article-title":"Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics","volume":"52","author":"Dahesh","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib20","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1093\/jac\/dkw320","article-title":"Description and characterization of a penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis clone isolated from blood in three epidemiologically linked patients","volume":"71","author":"Fuursted","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/jmbi.2000.3740","article-title":"The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance","volume":"299","author":"Gordon","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ajpath.2020.04.014_bib22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/AAC.00915-09","article-title":"Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin","volume":"54","author":"Haenni","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib23","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jac\/dkv022","article-title":"Classification of group B streptococci with reduced beta-lactam susceptibility (GBS-RBS) based on the amino acid substitutions in PBPs","volume":"70","author":"Kimura","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib24","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/AAC.00185-08","article-title":"First molecular characterization of group B Streptococci with reduced penicillin susceptibility","volume":"52","author":"Kimura","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/jac\/dkt060","article-title":"High cephalosporin resistance due to amino acid substitutions in PBP1A and PBP2X in a clinical isolate of group B Streptococcus","volume":"68","author":"Kimura","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1348-0421.12667","article-title":"Potential effect of selective pressure with different beta-lactam molecules on the emergence of reduced susceptibility to beta-lactams in group B Streptococci","volume":"63","author":"Koide","year":"2019","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.ajpath.2020.04.014_bib27","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/AAC.01243-10","article-title":"Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy","volume":"55","author":"Longtin","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib28","doi-asserted-by":"crossref","first-page":"574.e7","DOI":"10.1016\/j.cmi.2017.02.021","article-title":"Active bacterial core surveillance t: short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA","volume":"23","author":"Metcalf","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajpath.2020.04.014_bib29","doi-asserted-by":"crossref","first-page":"19175","DOI":"10.1074\/jbc.274.27.19175","article-title":"Mutations in the active site of penicillin-binding protein PBP2x from Streptococcus pneumoniae: role in the specificity for beta-lactam antibiotics","volume":"274","author":"Mouz","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2020.04.014_bib30","doi-asserted-by":"crossref","first-page":"13403","DOI":"10.1073\/pnas.95.23.13403","article-title":"Identification of a structural determinant for resistance to beta-lactam antibiotics in gram-positive bacteria","volume":"95","author":"Mouz","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2020.04.014_bib31","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1128\/AAC.00596-08","article-title":"Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility","volume":"52","author":"Nagano","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkr546","article-title":"Nosocomial spread of multidrug-resistant group B streptococci with reduced penicillin susceptibility belonging to clonal complex 1","volume":"67","author":"Nagano","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib33","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1128\/JCM.01291-14","article-title":"Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility","volume":"52","author":"Nagano","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajpath.2020.04.014_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nsb0396-284","article-title":"X-ray structure of Streptococcus pneumoniae PBP2x, a primary penicillin target enzyme","volume":"3","author":"Pares","year":"1996","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.ajpath.2020.04.014_bib35","doi-asserted-by":"crossref","first-page":"16463","DOI":"10.1074\/jbc.M313492200","article-title":"A PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to beta-lactam antibiotics","volume":"279","author":"Pernot","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2020.04.014_bib36","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/mdr.2017.0013","article-title":"Analysis of point mutations in the pbp2x, pbp2b, and pbp1a genes of Streptococcus agalactiae and their relation with a reduced susceptibility to cephalosporins","volume":"23","author":"Piccinelli","year":"2017","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ajpath.2020.04.014_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1574-6976.2007.00095.x","article-title":"Penicillin-binding proteins and beta-lactam resistance","volume":"32","author":"Zapun","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.ajpath.2020.04.014_bib38","doi-asserted-by":"crossref","first-page":"e01428-19","DOI":"10.1128\/AEM.01428-19","article-title":"Streptococcus pyogenes transcriptome changes in the inflammatory environment of necrotizing fasciitis","volume":"85","author":"Hirose","year":"2019","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ajpath.2020.04.014_bib39","doi-asserted-by":"crossref","first-page":"e00460-17","DOI":"10.1128\/mSphereDirect.00460-17","article-title":"Novel genes required for the fitness of Streptococcus pyogenes in human saliva","volume":"2","author":"Zhu","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.ajpath.2020.04.014_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI124994","article-title":"Gene fitness landscape of group A streptococcus during necrotizing myositis","volume":"129","author":"Zhu","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2020.04.014_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ajpath.2016.11.003","article-title":"Contribution of secreted NADase and streptolysin O to the pathogenesis of epidemic serotype M1 Streptococcus pyogenes infections","volume":"187","author":"Zhu","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2020.04.014_bib42","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1172\/JCI82478","article-title":"A molecular trigger for intercontinental epidemics of group A Streptococcus","volume":"125","author":"Zhu","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2020.04.014_bib43","doi-asserted-by":"crossref","first-page":"e00403-16","DOI":"10.1128\/mBio.00403-16","article-title":"Transcriptome remodeling contributes to epidemic disease caused by the human pathogen Streptococcus pyogenes","volume":"7","author":"Beres","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.ajpath.2020.04.014_bib44","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1073\/pnas.0911811107","article-title":"Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis","volume":"107","author":"Olsen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2020.04.014_bib45","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dkp458","article-title":"Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone","volume":"65","author":"Gaudreau","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib46","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/jac\/dkp374","article-title":"Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from a sacral decubitus ulcer","volume":"64","author":"Nagano","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib47","series-title":"Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery","author":"Quesenberry","year":"2012"},{"key":"10.1016\/j.ajpath.2020.04.014_bib48","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/AAC.44.6.1575-1577.2000","article-title":"Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice","volume":"44","author":"Azoulay-Dupuis","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib49","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1073\/pnas.95.7.3949","article-title":"Virulence of antibiotic-resistant Salmonella typhimurium","volume":"95","author":"Bjorkman","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2020.04.014_bib50","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/jac\/dky264","article-title":"Development of macrolide resistance in Bordetella bronchiseptica is associated with the loss of virulence","volume":"73","author":"Dewan","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajpath.2020.04.014_bib51","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ng.2747","article-title":"Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis","volume":"45","author":"Farhat","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2020.04.014_bib52","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ncomms1724","article-title":"Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis","volume":"3","author":"Lee","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2020.04.014_bib53","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1086\/520934","article-title":"Within-host evolution for the invasiveness of commensal bacteria: an experimental study of bacteremias resulting from Haemophilus influenzae nasal carriage","volume":"196","author":"Margolis","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajpath.2020.04.014_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/320992","article-title":"Complex relationship between acquisition of beta-lactam resistance and loss of virulence in Streptococcus pneumoniae","volume":"184","author":"Rieux","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajpath.2020.04.014_bib55","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2217\/fmb-2017-0022","article-title":"In\u00a0vitro and in\u00a0vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D","volume":"12","author":"Rifat","year":"2017","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ajpath.2020.04.014_bib56","doi-asserted-by":"crossref","first-page":"e94953","DOI":"10.1371\/journal.pone.0094953","article-title":"Reduced virulence of an extensively drug-resistant outbreak strain of Mycobacterium tuberculosis in a murine model","volume":"9","author":"Smith","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2020.04.014_bib57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/mdr.2017.0326","article-title":"Molecular analysis of PBP1A in Streptococcus pneumoniae isolated from clinical and normal flora samples in Tehran, Iran: a multicenter study","volume":"25","author":"Ahmadi","year":"2019","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ajpath.2020.04.014_bib58","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s13104-018-3719-5","article-title":"Analysis of amino acid motif of penicillin-binding proteins 1a, 2b, and 2x in invasive Streptococcus pneumoniae nonsusceptible to penicillin isolated from pediatric patients in Casablanca, Morocco","volume":"11","author":"Diawara","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ajpath.2020.04.014_bib59","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/mdr.2015.0261","article-title":"Important mutations contributing to high-level penicillin resistance in Taiwan(19F)-14, Taiwan(23F)-15, and Spain(23F)-1 of Streptococcus pneumoniae isolated from Taiwan","volume":"22","author":"Liu","year":"2016","journal-title":"Microb Drug Resist"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944020302364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944020302364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:37:02Z","timestamp":1757695022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944020302364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0002944020302364"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2020.04.014","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Single Amino Acid Replacement in Penicillin-Binding Protein 2X in Streptococcus pyogenes Significantly Increases Fitness on Subtherapeutic Benzylpenicillin Treatment in a Mouse Model of Necrotizing\u00a0Myositis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2020.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}